CCK₁ Antagonists: Are They Ready for Clinical Use?

Publisher： Karger

E-ISSN： 1421-9875|24|1-2|70-82

ISSN： 0257-2753

Source： Digestive Diseases, Vol.24, Iss.1-2, 2006-05, pp. : 70-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gonadotropin-Releasing Hormone Antagonists: Pharmacology and Clinical Use in Women

By Weiss J.M. Diedrich K. Ludwig M.

Treatments in Endocrinology, Vol. 1, Iss. 5, 2002-01 ,pp. : 281-291

Adis International

Access to resources Recommend Favorite

BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?

By Puxeddu Efisio Filetti Sebastiano

Endocrine, Vol. 45, Iss. 3, 2014-04 ,pp. : 341-343

Springer Publishing Company

Access to resources Recommend Favorite

TRANSCEND Aftermath: Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) at the Clinical Crossroad

By Volpe Massimo

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

AT1 Receptor Antagonists

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 1, 2004-01 ,pp. : 69-77

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis antagonists: current clinical trials

By Brem S.

Angiogenesis, Vol. 2, Iss. 1, 1998-01 ,pp. : 9-20

Springer Publishing Company

Access to resources Recommend Favorite